Loading clinical trials...
Loading clinical trials...
The Effect of Tecfidera® (Dimethyl Fumarate, BG00012) on the Gut Microbiota as a Causal Factor for Gastro Intestinal Associated Adverse Events.
Conditions
Interventions
dimethyl fumarate
injectable MS DMT
Locations
7
Norway
Research site
Drammen, Norway
Research site
Haukeland, Norway
Research Site
Lillehammer, Norway
Research site
Lørenskog, Norway
Research site
Molde, Norway
Research site
Oslo, Norway
Start Date
November 6, 2015
Primary Completion Date
June 12, 2017
Completion Date
June 12, 2017
Last Updated
September 5, 2021
NCT05359653
NCT06390930
NCT03401879
NCT06389968
NCT05834855
NCT06413602
Lead Sponsor
Biogen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions